---
$id: https://graph.org.ai/products/commodity/51131754
$type: Product
source: UNSPSC
code: "51131754"
title: "Taprostene sodium"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Taprostene sodium

**UNSPSC Code**: 51131754
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiplatelet agent with the molecular formula C24H29O5.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3M078713KZ, chemically known as benzoic acid, 3-((z)-((3ar,4r,5r,6as)-4-((1e,3s)-3-cyclohexyl-3-hydroxy-1-propenyl)hexahydro-5-hydroxy-2h-cyclopenta(b)furan-2-ylidene)methyl)-, monosodium salt, but more generally known as taprostene sodium, which bears US NIH Compound Identifier 6437844. European Medicines Agency schedules taprostene sodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10831MIG. Most nations, for tariff purposes, schedule taprostene sodium under HS 29375000. SMILES: C1CC(CC(C1)C(=O)[O-])/C=C\2/C[C@H]3[C@@H](O2)C[C@H]([C@@H]3/C=C/[C@H](C4CCCCC4)O)O.[NA+].

